– Healthcare and Pharma Veteran James Karis joins as company expands its “app”-centric approach to new cancers
PALO ALTO, Calif.–(BUSINESS WIRE)–CollabRx, the company that leverages information technology to inform personalized cancer treatment planning, announces the release of a Targeted Therapy Finder application (“app”) for lung cancer. Targeted Therapy Finder apps are dynamically updated online resources that enable physicians and patients to identify diagnostic tests and clinical trials associated with therapies that “target” the unique genetic profiles of patients’ tumors. The Targeted Therapy Finder – Lung Cancer app builds on the success of the first such app released by CollabRx earlier this year for melanoma. The melanoma app was created in partnership with the American Society of Clinical Oncology (ASCO) as a first-of-its kind resource for cancer patients and physicians. continue reading
